Free Trial

908 Devices (MASS) Competitors

908 Devices logo
$8.51 +0.11 (+1.31%)
Closing price 04:00 PM Eastern
Extended Trading
$8.51 0.00 (0.00%)
As of 05:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MASS vs. ALNT, EYPT, AEHR, TRNS, CTKB, LAB, QSI, FEIM, QTRX, and PRE

Should you be buying 908 Devices stock or one of its competitors? The main competitors of 908 Devices include Allient (ALNT), Eyepoint Pharmaceuticals (EYPT), Aehr Test Systems (AEHR), Transcat (TRNS), Cytek Biosciences (CTKB), Standard BioTools (LAB), Quantum-Si (QSI), Frequency Electronics (FEIM), Quanterix (QTRX), and Prenetics Global (PRE). These companies are all part of the "measuring and control equipment" industry.

908 Devices vs. Its Competitors

908 Devices (NASDAQ:MASS) and Allient (NASDAQ:ALNT) are both small-cap measuring and control equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, media sentiment, valuation and earnings.

Allient has a net margin of 2.75% compared to 908 Devices' net margin of -30.54%. Allient's return on equity of 9.97% beat 908 Devices' return on equity.

Company Net Margins Return on Equity Return on Assets
908 Devices-30.54% -24.30% -18.55%
Allient 2.75%9.97%4.67%

908 Devices has a beta of 0.46, indicating that its share price is 54% less volatile than the S&P 500. Comparatively, Allient has a beta of 1.51, indicating that its share price is 51% more volatile than the S&P 500.

88.1% of 908 Devices shares are owned by institutional investors. Comparatively, 61.6% of Allient shares are owned by institutional investors. 23.7% of 908 Devices shares are owned by insiders. Comparatively, 15.6% of Allient shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Allient had 7 more articles in the media than 908 Devices. MarketBeat recorded 14 mentions for Allient and 7 mentions for 908 Devices. Allient's average media sentiment score of 0.65 beat 908 Devices' score of -0.07 indicating that Allient is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
908 Devices
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Allient
3 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Allient has higher revenue and earnings than 908 Devices. 908 Devices is trading at a lower price-to-earnings ratio than Allient, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
908 Devices$59.63M5.12-$72.21M-$0.54-15.76
Allient$519.60M1.79$13.17M$0.8663.86

908 Devices presently has a consensus price target of $8.00, suggesting a potential downside of 5.99%. Allient has a consensus price target of $47.50, suggesting a potential downside of 13.51%. Given 908 Devices' stronger consensus rating and higher possible upside, equities research analysts clearly believe 908 Devices is more favorable than Allient.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
908 Devices
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.80
Allient
0 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Allient beats 908 Devices on 10 of the 17 factors compared between the two stocks.

Get 908 Devices News Delivered to You Automatically

Sign up to receive the latest news and ratings for MASS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MASS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MASS vs. The Competition

Metric908 DevicesMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$305.17M$7.59B$6.14B$10.76B
Dividend YieldN/A1.13%5.71%4.83%
P/E Ratio-15.7627.3629.8028.54
Price / Sales5.1228.19499.08189.72
Price / CashN/A22.5936.6160.67
Price / Book2.595.2612.016.60
Net Income-$72.21M$178.09M$3.32B$276.82M
7 Day Performance-0.58%1.31%1.59%1.99%
1 Month Performance12.57%2.15%6.15%2.56%
1 Year Performance157.10%5.12%61.11%32.85%

908 Devices Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MASS
908 Devices
1.3195 of 5 stars
$8.51
+1.3%
$8.00
-6.0%
+146.3%$305.17M$59.63M-15.7660News Coverage
Analyst Forecast
ALNT
Allient
2.7035 of 5 stars
$51.05
+3.7%
$47.50
-7.0%
+228.4%$834.64M$529.97M59.362,525News Coverage
Analyst Forecast
Gap Up
EYPT
Eyepoint Pharmaceuticals
2.2689 of 5 stars
$12.03
+3.4%
$28.67
+138.3%
+15.5%$801.63M$43.27M-4.49120
AEHR
Aehr Test Systems
2.1061 of 5 stars
$28.80
+16.3%
$24.00
-16.7%
+64.1%$742.96M$58.97M-130.9190Analyst Forecast
Gap Up
TRNS
Transcat
4.0438 of 5 stars
$71.01
+2.5%
$112.20
+58.0%
-37.8%$645.35M$278.42M49.661,245Analyst Upgrade
CTKB
Cytek Biosciences
1.3344 of 5 stars
$4.04
+2.3%
$5.60
+38.6%
-14.2%$502.53M$200.45M-80.80500Analyst Forecast
LAB
Standard BioTools
2.024 of 5 stars
$1.28
+0.8%
$1.55
+21.1%
-22.5%$485.13M$174.43M-4.00620News Coverage
QSI
Quantum-Si
2.6108 of 5 stars
$2.59
+13.6%
$3.48
+34.2%
+177.7%$461.69M$3.06M-3.81150Gap Up
FEIM
Frequency Electronics
2.5505 of 5 stars
$36.72
+7.9%
$43.00
+17.1%
+224.3%$331.67M$69.81M16.04200Positive News
QTRX
Quanterix
2.3879 of 5 stars
$5.90
+0.7%
$11.75
+99.2%
-52.3%$272.29M$137.42M-3.24460News Coverage
Gap Up
PRE
Prenetics Global
0.6819 of 5 stars
$16.24
+8.3%
$9.00
-44.6%
+267.4%$194.77M$30.62M-4.071

Related Companies and Tools


This page (NASDAQ:MASS) was last updated on 10/24/2025 by MarketBeat.com Staff
From Our Partners